Skip to main content
BioInfra Co.,Ltd. logo

BioInfra Co.,Ltd. — Investor Relations & Filings

Ticker · 199730 ISIN · KR7199730003 KO Professional, scientific and technical activities
Filings indexed 88 across all filing types
Latest filing 2024-07-01 Regulatory Filings
Country KR South Korea
Listing KO 199730

About BioInfra Co.,Ltd.

http://bioinfra.co.kr/?lang=en

BioInfra Co., Ltd. is a biotechnology and healthcare company specializing in innovative solutions for disease prevention and early detection, with a primary focus on oncology. The company's core technology is a proprietary multi-biomarker blood test for the early screening of eight major cancers, including lung, liver, stomach, colorectal, prostate, breast, pancreatic, and ovarian cancer. This in vitro diagnostic tool analyzes a small blood sample to assess cancer risk, aiming to improve patient outcomes through early intervention. Beyond diagnostics, BioInfra also engages in pharmaceutical research and development, offering clinical research services and developing cancer gene treatments.

Recent filings

Filing Released Lang Actions
[기재정정]신규시설투자등
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Bioinfra) regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes to investment amounts and reasons for the adjustment. Since this is a specific regulatory disclosure regarding capital expenditure and investment updates that does not fit into the other specific categories like M&A or Share Issues, it is classified as a Regulatory Filing (RNS).
2024-07-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Choi Yoon Ho) of Bioinfra. This type of filing, which discloses personal share transactions or changes in ownership by company insiders, is classified as 'Director's Dealing' (DIRS) in the provided schema.
2024-06-13 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'BioInfra Co., Ltd.' covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial statements, management discussion and analysis, and operational information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share acquisition (stock option exercise) by an executive (Hwang Gyu-sang) of Bioinfra. This is a standard regulatory filing for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2024-05-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details a transaction (a sale of shares) by an executive (Hwang Gyu-sang) of the company Bioinfra. This type of filing is a standard regulatory requirement for insider trading/shareholding disclosures, which corresponds to the 'Director's Dealing' category.
2024-04-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (disposal of shares) by an executive (Hwang Gyu-sang) of Bioinfra. This type of filing is a standard regulatory requirement for insider trading/director dealings in South Korea, which corresponds to the 'Director's Dealing' category.
2024-04-01 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.